Low baseline antibody level to diphtheria is associated with poor response to conjugated pneumococcal vaccine in

M A Shelly1, M E Pichichero, J J Treanor

  • 1Department of Medicine, Highland Hospital Rochester, New York, USA.

Insights

Low immunity to carrier proteins like diphtheria may explain why some older adults do not respond well to conjugated pneumococcal vaccines. This impacts the effectiveness of these important immunizations in the elderly population.

Area of Science:

  • Immunology
  • Vaccinology
  • Geriatric Medicine

Background:

  • Conjugating polysaccharide antigens to protein carriers enhances immunogenicity in infants.
  • However, conjugated pneumococcal vaccines have shown disappointing results in older adults.
  • Low pre-existing immunity to carrier proteins in the elderly may hinder T-cell-dependent responses.

Purpose of the Study:

  • To investigate the impact of pre-existing immunity to carrier proteins on the immune response to pneumococcal vaccines in older adults.
  • To compare immune responses between younger and older adults vaccinated with pneumococcal polysaccharide or conjugate vaccines.

Main Methods:

  • Immunization of 49 older adults (60-78 years) and 50 younger adults (18-45 years) with pneumococcal polysaccharide vaccine or CRM197-conjugated pneumococcal oligosaccharide vaccine.
  • Analysis of pre- and post-vaccination sera for antibodies to pneumococcal serotypes 14 and 6B, and diphtheria toxin using ELISA.
  • Correlation of baseline diphtheria toxin antibody levels with post-vaccination antibody levels to pneumococcal antigens.

Main Results:

  • Older adults had significantly lower baseline antibody levels to diphtheria toxin compared to younger adults.
  • Higher baseline diphtheria toxin antibody levels correlated with increased post-vaccination antibody levels to pneumococcal serotype 6B.
  • Antibody levels to pneumococcal serotype 14 showed a similar trend, particularly in the older adult group.

Conclusions:

  • Low pre-existing immunity to diphtheria protein may contribute to diminished responses to conjugate pneumococcal vaccines in older adults.
  • This finding suggests a potential mechanism for vaccine failure in the elderly and highlights the importance of carrier protein immunogenicity.

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Vaccinations01:51

Vaccinations

Overview
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...